Backgrounds/Aims: Acacetin, a natural flavonoid compound, has been proven to exert antiinflammatory and immunomodulatory effects. Kv1.3 channels, highly expressed in human T cells, are attractive therapeutic targets to treat inflammatory and immunological disorders. The present study was designed to characterize the inhibition of Kv1.3 channels by Acacetin in human T cells and examine its role in T cell activation. Methods: Whole-cell patch-clamp was applied to record the Kv1.3 and K Ca currents in human T cells; Western blot was used to detect Kv1.3 expression as well as NFAT1 and NF-κB activity; Fluo-4, CCK-8 and an ELISA kit were used to measure Ca 2+ influx, proliferation, and IL-2 secretion, respectively. Results: Acacetin decreased the Kv1.3 current, accelerated the decay rate and negatively shifted the steadystate inactivation curves in a concentration-dependent manner. The IC 50 values at +40 mV for peak and the current at end of pulse were 21.09 ± 2.75 and 3.63 ± 0.25 μmol/L, respectively. Treatment with Acacetin for 24 h significantly inhibited Kv1.3 protein expression. Additionally, paralleling Kv1.3 inhibition, Acacetin also inhibited Ca 2+ influx, the Ca 2+ -activated transcription factors NFAT1, NF-κB p65/p50 activity, and proliferation as well as IL-2 production. Small interfering RNA against Kv1.3 reduced the inhibitory effect of Acacetin on IL-2 secretion. Conclusions: Acacetin blocks the Kv1.3 channel and inhibits human T cell activation. This action most likely contributes to its immunomodulatory and anti-inflammatory actions.
Introduction
Acacetin (5, 7-dihydroxy-4'-methoxyflavone), a natural flavonoid compound, has been reported to have anti-peroxidative, anti-proliferative and anti-inflammatory activities [1, 2] . Importantly, it has been demonstrated that Acacetin significantly inhibits the concanavalin 10 , adjusted to pH 7.2 with KOH. For some experiments recording K Ca , the external solution was replaced with a K + Ringer solution, which featured identical ingredients, except that all NaCl was substituted with KCl. Voltage pulse protocols are described in the Results and in the Figure  Legends . The time constant for the Kv1.3 current decay, % inhibition, IC 50 (concentration required for 50% inhibition of the channel currents), Hill coefficient, membrane conductance (G), half-maximum voltage of activation or inactivation (V 1/2 ) and the slope factors (κ) were all acquired using the same equations as previously described [14] . The decay phase of the Kv1.3 current at +40 mV was fitted to a mono-exponential equation. The inhibition % was defined as (I control -I drug )/I control *100%. G was defined as I/(V-E rev ), where I is the peak amplitude, V is the test voltage, and E rev is the reversal potential (-90 mV) of the Kv1.3 currents. The steady-state inactivation curve was studied using a double-pulse protocol, in which the test voltage was stepped to +40 mV, 200 ms long, and preceded by 30 s preconditioning pulses from -80 to 0 mV in 10 mV steps. The data for activation and steady-state inactivation were fitted with the Boltzmann equation to obtain V 1/2 and the slope factor. The concentration-dependent shift in the inactivation V 1/2 (∆V) was determined as the difference between V 1/2 values in the control and with various concentrations of Acacetin application. Exp (∆V/κ) was then plotted with the Acacetin concentrations and linear fit was used to obtain the reciprocal of the slope, K i. The pCLAMP 9.0 software (Molecular Devices, Union City, CA, USA) was used for data acquisition and Origin 8.5 (OriginLab Corporation, Northampton, MA, USA) for the data analysis. No leak subtraction protocol was applied.
Cell viability assay
Jurkat cells were seeded into a 24-well plate and treated with Acacetin at various time points. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8, Dojindo Molecular Technologies, Tokyo, Japan). CCK-8 solution (20 μL) was added to every well for the last 2 h, and the optical density (OD) value of each well at 450 nm wavelength was recorded. The cell viability is calculated as the percentage of (OD test -OD blank )/ (OD control -OD blank ), where OD test is the OD value of the cells exposed to Acacetin, OD control is the OD of the control sample and OD blank is the OD of the wells without Jurkat cells. Alternatively, cell viability was determined using a Trypan blue dye exclusion assay as described previously [11] . Values were calculated relative to DMSO-treated cells.
RNA isolation and quantitative real-time PCR
Jurkat cells were seeded and treated with various concentrations (10, 30 , 100 μmol/L) of Acacetin for 24 h. The protocols for total RNA extraction and cDNA synthesis were performed as described in our previous paper [11] . The primers used are as follows: Kv1.3 forward primer: 5'-TTCTCCTTCGAACTGCTGGT-3', reverse primer: 5'-TGAAGATGCGGAAGACCCTT-3'; GAPDH forward primer: 5'-CATGAGAAGTATGACAACAGCCT-3', reverse primer: 5'-AGTCCTTCCACGATACCAAAGT-3'. In all experiments, negative controls were applied in the absence of the reverse transcriptase reaction and GAPDH were used as controls. The relative expression quantity 2 -△△Ct value was calculated to compare the differences among the groups.
Western Blot
For the measurement of Kv1.3 channel protein expression levels, Jurkat cells were treated with 10, 30 or 100 μmol/L Acacetin for 24 h. To measure NFAT1 and NF-κB activity, Jurkat cells were stimulated with PHA (5 μg/mL) and PMA (80 nmol/L) for 4 h with or without the 30 min pretreatment of 10, 30 or 100 μmol/L Acacetin. Next, the Jurkat cell lysate was prepared and analyzed as described previously [14] . Primary antibodies against Kv1.3 (Alomone Labs), NFAT1 (Genetex, Irvine, CA, USA), phospho-NF-κB p65/ p50 (Cell Signaling Technology, Beverly, MA, USA), and GAPDH (Santa Cruz Biotechnology Inc, CA, USA) were applied. The protein expression levels were detected and analyzed by enhanced chemiluminescence using Image Lab Software (Bio-Rad, Richmond, CA, USA). GAPDH expression was used as an internal reference.
Intracellular calcium measurement
Intracellular calcium was measured as described previously [11] . Briefly, Jurkat cells were loaded with Fluo-4 AM and seeded into 96-well plate (2×10 ] = K d *(F-F min )/(F max -F), as described in our previous study [11] .
Determination of cell proliferation
Cell proliferation was measured using CCK-8 as described above. CD4 + T cells were seeded in 96-well round-bottom plates at 5×10 5 cells per well in 200 μL complete medium. Every group contained 3-4 duplicates. T cells were pre-treated with 3, 10, 30, or 100 μmol/L Acacetin for 30 min, then 1 μg/mL soluble purified anti-CD3 and anti-CD28 antibodies (eBioscience, San Diego, CA, USA) were added to stimulate the CD4 + T cells for 3 days.
IL-2 measurement by ELISA
IL-2 production from Jurkat cells was measured using an ELISA kit (eBioscience) following the manufacturer's instructions. Cells were stimulated using PHA (5 μg/mL) and PMA (80 nmol/L) for 24 h. Acacetin in various concentrations was added 30 min prior to stimulation. The supernatants were collected for subsequent assays. Each experiment was repeated at least three times in duplicate.
Knockdown of Kv1.3 expression with small interfering RNA
Human Jurkat cell lines stably transfected with lentivirus-delivered negative control (NC)-siRNA or Kv1.3-siRNA were provided by the Genepharma Company (Shanghai, China). A Western blot was performed to confirm the efficiency of siRNA knockdown. The cells were pre-incubated with 100 μmol/L Acacetin for 30 min, then stimulated with PHA + PMA for 24 h. The supernatants were collected for IL-2 measurement.
Statistical Analysis
All results are presented as the mean ± SEM. The significance of differences before and after drug treatment was evaluated using paired t-test. Comparisons between groups were carried out by analysis of variance with Turkey's post-test. Significance was set at P<0.05.
Results

Acacetin blocks Kv1.3 channel currents in Human T cells
We examined the effects of Acacetin on Kv1.3 currents in Jurkat cells, a human T cellline, using 300 ms pulses at test potentials from -80 to +60 mV in 10 mV steps from a holding potential of -80 mV. In the control condition, the Kv1.3 currents were characterized by rapid activation and slow inactivation at potentials positive to -30 mV (Fig. 1A) , as we previously reported [14] . However, the currents became smaller and appeared to inactivate faster (Fig.  1B) after the application of 10 μmol/L Acacetin, and the effect partially recovered upon washout (Fig. 1C) . Similar results were obtained in peripheral blood T cells (PBTC) (Fig.1  D-F) . We then investigated the time course block in PBTC using a voltage step to +40 mV from a holding potential of -80 mV (0.1 Hz). As shown in Fig. 1G , the steady-state block was reached within 15 min. The current amplitude was measured both at the peak (open circle, peak current) and at the end of a pulse to +40 mV (filled circle, current at the end of the pulse). The inhibitory effect gradually recovered upon washout. Peak currents were nearly reversible, but currents at the end of the pulse recovered only partially. Fig. 1H shows the corresponding representative current traces.
Concentration-dependent block of Kv1.3 channel currents by Acacetin in Jurkat cells
The effects of Acacetin on Kv1.3 channels over a wide range of concentrations, from 0.3 to 100 μmol/L, confirmed that this blocking effect was concentration-dependent. Kv1.3 currents were elicited with repetitive 250 ms depolarizing pulses at +40 mV from a holding potential of -80 mV every 10 s. Fig. 2A shows the representative superimposed current traces recorded in a single Jurkat cell in the absence and presence of 3, 10, or 100 μmol/L Acacetin.
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The dose-dependent inhibition of the peak current and the current at the end of the pulse were analyzed quantitatively ( [14, 23, 24] , Acacetin accelerated the channel decay rate in a concentration-dependent manner.
Blocking kinetics of Acacetin on Kv1.3 channels
We further evaluated the biophysical effects of Acacetin on Kv1.3 channels in Jurkat cells. The current density-voltage relationships for the peak currents and the currents at the end of the pulse, as in Fig. 3A and 3B, indicated that Acacetin reduced both current amplitudes 3C ). In the presence of Acacetin, the inhibition percentage increased steeply between -40 and 0 mV, from 34.1% to 56.8%, corresponding to the voltage range for channel opening. This inhibition reached a plateau value between +10 and +60 mV when the Kv1.3 channels were fully activated (Fig. 3C ). These data suggest that Acacetin may bind to the open form of the Kv1.3 channels.
To further determine whether blocking the Kv1.3 channels with Acacetin requires channel opening, we recorded the currents in Jurkat cells before and after a pulse-free period of incubation with the compound. During the pulse pause, the membrane potential was kept at -80 mV to ensure all channels were in the close state. After resuming the voltage steps, Acacetin did not affect the peak current at pulse 1 (81.13 vs 81.27 pA/pF under control conditions) but significantly accelerated the decay of the Kv1.3 channel current (the time constants of the decay were 268.54 ms under control and 148.74 ms at pulse 1). These results indicate that Acacetin preferentially binds to the open state of the Kv1.3 channel rather than the close state.
To investigate the effects of Acacetin on the voltage dependence of channel availability, steady-state inactivation curves were generated using standard double-pulse protocols [14] . The resulting curves were fitted with the Boltzman equation to obtain V 1/2 and κ in Fig. 3E . In control conditions, the V 1/2 value was -40.91 ± 0.96 and κ was 3.98 ± 0.42 mV. Acacetin caused a negative shift of the steady-state inactivation curves in a concentration-dependent fashion (-46.32 ± 0.99 at 10, -51.94 ± 1.08 at 30 μmol/L Acacetin; P<0.05 and P<0.001, respectively), which suggests that Acacetin may block the inactivated-state channel. However, Acacetin did not change the κ value (4.53 ± 0.33 at 10, 5.28 ± 0.36 at 30 μmol/L; P>0.05). The K i value for the possible Acacetin-induced inhibitory effect in the inactivated state was calculated as 3.85 ± 1.17 μmol/L (Fig. 3F) . Thus, the effect of Acacetin on channel inactivation was 5 times more potent than on the peak current (21.09 ± 2.75 μmol/L), whereas it was equally potent on the current at the end of the pulse (3.63 ± 0.25 μmol/L).
Acacetin does not block KCa channel currents in human T cells
We further examined the effects of Acacetin on K Ca channel in human T cells. The main K Ca channel involved in the Ca 2+ signaling of Jurkat cells is K Ca 2.2, whereas K Ca 3.1 is the main Zhao
K Ca channel in PBTC [6, 25] . Therefore, we checked the blocking effect of Acacetin on K Ca currents in both of these two types of human T cells. K Ca channel currents were elicited by ramp pulse, as described previously [14] . The representative current traces in Jurkat T cells and PBTC are shown in Fig. 4A and 4C, respectively. To avoid mixture of the outward Kv channel currents, we measured the slope conductance between -120 and -40 mV by fitting the curve with a linear equation. Acacetin at 30 μmol/L had no apparent effects on the slope factor for K Ca in both Jurkat cells and human PBTC (Fig. 4B and 4D ). The slope conductance for Jurkat cells was 0.70 ± 0.04 nS in control condition, and 0.69 ± 0.05 nS after Acacetin application (n=5, P>0.05). Likewise, the slope conductance for PBTC was 0.92± 0.11 nS in control condition, and 0.94 ± 0.13 nS after Acacetin application (n=5, P>0.05). In Fig. 4E and 4F, to increase the slope conductance of K Ca current, we recorded the current in a K + Ringer solution (All NaCl was replaced by KCl), and found no block effect by Acacetin ( Acacetin was applied to the bath in the pulse-free condition for 8 min, then consecutive depolarization pulses were applied every 10 s. E. The steady-state inactivation curves in the absence and presence of 10 and 30 μmol/L Acacetin. The data were acquired from the normalized currents at +40 mV, which followed a 30 s pre-pulse of potentials between -80 mV and 0 mV, and fitted with the Boltzman equation. In the control condition, the V 1/2 value was -40.91 ± 0.96 and κ was 3.98 ± 0.42 mV. After 10 and 30 μmol/L Acacetin application, the V 1/2 value changed to -46.32 ± 0.99 and -51.94 ± 1.08 and the κ value changed to 4.53 ± 0.33 and 5.28 ± 0.36, respectively. We first recorded the control current after at least 10 min break-in, and then recorded the currents after 10 and 30 μmol/L Acacetin treatment on the same cell. F. Plot of Exp (∆V/κ) against the Acacetin concentration. Potential corresponding to the half-inactivation voltage V 1/2 and the slope factor κ were obtained from the curves in Fig. 3E .
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Cellular Physiology and Biochemistry inset). Therefore, our results suggest that Acacetin has no effect on K Ca in human T cells. Notably, Acacetin at 30 µmol/L blocks most of the current through Kv1.3 channels in Ringer solution (Fig. 4A ) but only 50% in K + Ringer solution (Fig. 4E) , which suggests that high extracellular K + might attenuate the block effect of Acacetin on Kv1.3 channels in Jurkat cells. In our previous report [26] , high extracellular K + also resulted in a reduced inhibitory effect of Ketanserin on Kv1.3 channels expressed in xenopus oocytes.
Effect of Acacetin on Kv1.3 channel mRNA and protein expression
In addition to acute inhibition of functional Kv1.3 channels, Kv1.3 blockers have been shown to produce anti-inflammatory and immunomodulatory effects through chronic reduction of the channel expression [11, 12, 14, 27] . Before analysis, we confirmed that treatment with 10, 30 or 100 μmol/L Acacetin for up to 24 h did not result in any cytotoxicity in Jurkat cells, as assessed using both a CCK-8 kit and trypan blue dye (Fig. 5A and Fig.  5B) . To test the effect of Acacetin on Kv1.3 channel expression, we exposed Jurkat cells to (24 h) and measured the effects on Kv1.3 mRNA and protein processing using real-time PCR and Western blot analysis. Treatment with Acacetin had no effect on mRNA expression (Fig. 5C ), but produced a concentration-dependent decrease in the amount of Kv1.3 protein (Fig. 5D and 5E ). On average, 10, 30 and 100 μmol/L Acacetin decreased Kv1.3 protein expression by 9%, 46% and 59%, respectively (Fig. 5E) .
Acacetin decreases the Ca2+ influx to Ca2+-depleted Jurkat cells
Many studies have shown that Kv1.3 channels control Ca 2+ homeostasis by maintaining the negative membrane potential in T cells and inhibition of Kv1.3 channels significantly depolarizes the membrane potential, reducing the Ca 2+ influx [11, 12, 14] . Our current-clamp recordings have shown that the RMP depolarized from -41.57 ± 0.90 mV in the control to -22.35 ± 1.66 mV (n=6, P<0.001)after 7-8 min application of 30 μmol/L Acacetin. To further confirm that Acacetin inhibits Ca 2+ influx, we measured the intracellular Ca 2+ concentration using a similar protocol as in previous studies [11] . Treatment of the cells with Acacetin (10, 30 or 100 μmol/L) for 30 min had no effects on TG-induced intracellular Ca 2+ , except at 100 μmol/L (Fig. 6A and 6B ) but significantly reduced the sustained Ca 2+ influx in a concentrationdependent manner (Fig. 6A and 6C ). On average, 10, 30 and 100 μmol/L Acacetin reduce Ca 2+ influx by 13.54%, 38.27%, 52.55%, respectively.
Acacetin modulates the transcription factors NFAT1 and NF-κB p65/p50
The activation of T cells is mediated by Ca 2+ influx and Ca
2+
-activated transcription factors such as NFAT and NF-κB in human T cells [9, 28] . We thus determined whether 
T cell proliferation and IL-2 secretion are inhibited by Acacetin
To determine whether Kv1.3 channel and Ca 2+ signaling pathway inhibition by Acacetin could result in functional immunosuppression, we evaluated T cell proliferation and IL-2 secretion. Cell proliferation was assessed in human anti-CD3/CD28-stimulated T cells using a CCK-8 kit, and IL-2 production in the cell culture supernatants of PMA/PHA-stimulated Jurkat cells was measured using ELISA. Treatment of the cells with Acacetin (3, 10, 30 or 100 μmol/L) resulted in a concentration-dependent reduction in the number of T cells (Fig. 8A ) and IL-2 secretion (Fig. 8B) . To prove that Kv1.3 is involved in the inhibitory effect of Acacetin on IL-2 secretion, we knocked down Kv1.3 expression in Jurkat cells by using specific Kv1.3 siRNA. We found that the transfection of kv1.3-siRNA resulted in 64.68% knockdown of the Kv1.3 protein and that NC-siRNA transfection caused no apparent change in the Kv1.3 channels (P=0.873, Fig. 8C ). Importantly, we demonstrated that knockdown of the Kv1.3 channels resulted in a reduced inhibitory effect of 100 μmol/L Acacetin on IL-2 secretion (34.07 ± 5.23% vs. NC-siRNA 68.35 ± 4.05%, P<0.01). In contrast, NC-siRNA had no effect on the Acacetin induced-inhibitory effects (68.35 ± 4.05% vs. Jurkat cell 78.14 ± 4.83%, P=0.196). Taken together, these results suggested that Acacetin most likely exerts its anti-inflammatory effect at least partly through Kv1.3 channels. 
Discussion
This is the first study to investigate the effect of Acacetin on Kv1.3 channels in human T cells. Our results demonstrated that Acacetin blocked the Kv1.3 channels in a voltage-and concentration-dependent fashion without an apparent effect on K Ca channel currents. Up to 24 h incubation with Acacetin had no significant effect on cell viability or Kv1.3 mRNA expression level but apparently inhibited Kv1.3 protein expression, which may contribute to its long-term inhibitory effect. Acacetin also inhibited the Ca 2+ influx and Ca
2+
-activated transcription factors NFAT1 and NF-κB p65/50. Similar to many other Kv1.3 blockers [11, 12] , Acacetin inhibited T cell proliferation as well as IL-2 secretion. Furthermore, siRNA knockdown of Kv1.3 channels reduced the inhibitory effect of Acacetin on IL-2 secretion. Therefore, our results suggest that Acacetin mediates its immunomodulatory and antiinflammatory effects by blocking Kv1.3 channels.
The Acacetin induced time-dependent blockade of Kv1.3 channels could be due to several mechanisms. As shown in Figs. 1, 2 and 3 , there was little inhibition of Kv1.3 at the onset of depolarization, indicating that Acacetin does not preferentially bind to the closed state of the channel. However, upon depolarization, Acacetin accelerated the time course of decay of the Kv1.3 currents in a concentration-dependent manner, correspondingly causing a greater reduction in the currents at the end of the pulse than the peak currents. These results suggest that Acacetin blocks the Kv1.3 channel open state and/or binds the inactivated state of the channel. As shown in Fig. 3 , Acacetin blocked the Kv1.3 channel in a voltage-dependent manner, and this inhibitory effect increased upon voltage range channel activation. Furthermore, Acacetin did not exert any obvious effect until the channel was first opened by a depolarization pulse. The voltage dependence and the development kinetics of the block strongly support a mechanism whereby Acacetin blocks the open state, which is the same mechanism previously observed for the Kv1.5 channel [29] . However, unlike other open channel blockers of the Kv1.3 channel [23, 30] , Acacetin failed to cause a crossover phenomenon of tail current traces, which may indicate that Acacetin is not a pure Kv1.3 open channel blocker. Indeed, Acacetin might also inhibit the inactivated-state channel, which is reflected in the negatively shift of the steady-state inactivation curves in a concentrationdependent manner. Affinity for both the open and the inactivated-state has been previously described for other Kv1.3 channel blockers, including FK-506, verapamil, diphenyl phosphine oxide-1 and 18β-glycyrrhetinic acid [11, 14, 24, 31] .
Blockade of the Kv1.3 channels inhibits T cell activation by depolarizing the membrane potential, thereby attenuating the Ca 2+ signaling and subsequent cell proliferation [6, 9, 14, 32, 33] . These characteristic features are clearly demonstrated for Acacetin in the present study. Acacetin in concentrations that block the Kv1.3 channel depolarized the membrane potential, blunted Ca 2+ influx, down-regulated the Ca 2+ -activated transcription factors NFAT1 and NF-κB p65/p50, and inhibited T cell proliferation and production of IL-2. Furthermore, 24 h incubation with Acacetin caused inhibition of Kv1.3 protein expression, which may strengthen the long-term effect of Acacetin on Kv1.3 channels. However, 24 h incubation with Acacetin had no effect on the mRNA expression of Kv1.3, and so we may conclude that Acacetin inhibited Kv1.3 protein expression by targeting the post-transcriptional mechanism. In addition, our electrophysiological data shows that acute application of 30 µmol/L Acacetin blocked the Kv1.3 channel, but had little effect on the K Ca channels, which should make Acacetin ideal for specific immune suppression, i.e., inhibiting the autoimmune reaction without compromising the physiological immune response. The latter is based on the up-regulation of the K Ca channel expression in activated naïve and central memory T cells. However, whether Acacetin has a direct blocking effect on CRAC channels, through which Ca 2+ entry mediates T cell activation, requires further investigation. Acacetin may also directly target the inflammation-related transcription factors [34] or the inflammatory intermediates iNOS and COX-2 [2] . Consistent with these findings, in animal models, Acacetin can ameliorate autoimmune delayed-type hypersensitivity and have no obvious side effects [3] . This confers a therapeutic potential for Acacetin against human T cell-mediated inflammatory diseases, such as multiple sclerosis, rheumatoid arthritis, and psoriasis. 
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In summary, our data provide the first evidence that the direct inhibition of the Kv1.3 channel is likely involved in the mechanisms of Acacetin-induced anti-inflammatory and immunomodulatory effects.
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